(S)-4-(4-(3-Chloro-4-(1-(5-Fluoropyridin-2-Yl)-2-Hydroxyethoxy)Pyrazolo[1,5-A]Pyridin-6-Yl)-5-Methyl-1H-1,2,3-Triazol-1-Yl)Piperidine-1-Carbonitrile

1 trials

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

0 Completed trials

1 Sponsors

9 Countries

Phase III

Phase III: 1

Sponsors using this IMP

Eli Lilly & Co. 1

All trials

1 total

A Study of Vepugratinib (LY3866288) in Participants with Cancer in the Urinary Tract ( FORAGER-2 ) Pending

2025-522855-25-00 Phase III 9 countries Eli Lilly & Co.

Showing 1–1 of 1 trials

← All drugs A–Z